LuRa: Efficacy and Safety of Radium-223 Following [177Lu]Lu-PSMA-617 in Patients With Metastatic Castration-Resistant Prostate Cancer.
Saved in:
| Title: | LuRa: Efficacy and Safety of Radium-223 Following [177Lu]Lu-PSMA-617 in Patients With Metastatic Castration-Resistant Prostate Cancer. |
|---|---|
| Authors: | Zarka, Jabra1,2 (AUTHOR) zarka.jabra@mayo.edu, Juthani, Ronit3 (AUTHOR), Sartor, Oliver4 (AUTHOR), Muniz, Miguel1 (AUTHOR), Kase, Adam M.5 (AUTHOR), Riaz, Irbaz B.6 (AUTHOR), Naqvi, Arsalan6 (AUTHOR), Heath, Elisabeth1 (AUTHOR), Orme, Jacob J.1 (AUTHOR), Scharf, Zachary1 (AUTHOR), Belge Bilgin, Gokce7 (AUTHOR), Kwon, Eugene D.8 (AUTHOR), Jang, Albert1 (AUTHOR), Tarhini, Ali1 (AUTHOR), Johnson, Geoffrey B.7 (AUTHOR), Kendi, Ayse Tuba7 (AUTHOR), Thorpe, Matthew P.7 (AUTHOR), Patnaik, Mrinal S.2 (AUTHOR), Kusne, Yael2 (AUTHOR), Jacene, Heather9 (AUTHOR) |
| Source: | Clinical Genitourinary Cancer. Jun2026, Vol. 24 Issue 4, pN.PAG-N.PAG. 1p. |
| Database: | Academic Search Ultimate |
Be the first to leave a comment!
